Skip to main content
Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
2.930
-0.120 (-3.93%)
At close: Mar 9, 2026, 4:00 PM EDT
2.970
+0.040 (1.37%)
After-hours: Mar 9, 2026, 6:55 PM EDT

Gain Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
25
Market Cap
112.69M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024---
Dec 31, 202355.18K-77.46K-58.40%
Dec 31, 2022132.64K-1.29K-0.96%
Dec 31, 2021133.93K--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Codexis 52.93M
Gossamer Bio 44.05M
Equillium 4.39M
Coya Therapeutics 3.99M
Precision BioSciences 698.00K
Inovio Pharmaceuticals 182.34K
Genelux 8.00K
Revenue Rankings

GANX News

More News